Table of Content




1. Introduction
1.1. Definition of Nuclear Medicine
1.2. Scope of the Report
1.3. Research Methodology


2. Executive Summary
2.1. Key Findings
2.2. Market Snapshot
2.3. Key Trends


3. Market Dynamics
3.1. Market Drivers
3.1.1. Advancements in Nuclear Medicine Technology
3.1.2. Growing Incidence of Chronic Diseases
3.1.3. Increasing Adoption of Personalized Medicine
3.1.4. Other Market Drivers
3.2. Market Restraints
3.2.1. High Costs of Nuclear Medicine Procedures
3.2.2. Regulatory and Safety Concerns
3.2.3. Limited Availability of Radioactive Materials
3.2.4. Other Market Restraints
3.3. Market Opportunities
3.3.1. Innovations in Diagnostic and Therapeutic Products
3.3.2. Expansion of Healthcare Infrastructure
3.3.3. Increasing R&D Investments
3.3.4. Other Market Opportunities


4. Asia Pacific Nuclear Medicine Market Analysis
4.1. Market Size and Forecast (2024-2034)
4.2. Market Share Analysis by:
4.2.1. Product
4.2.1.1. Diagnostics
4.2.1.1.1. SPECT
4.2.1.1.2. PET
4.2.1.2. Therapeutics
4.2.1.2.1. Alpha Emitters
4.2.1.2.2. Beta Emitters
4.2.2. Application
4.2.2.1. Neurology
4.2.2.2. Cardiology
4.2.2.3. Oncology
4.2.2.4. Others
4.2.3. End User
4.2.3.1. Hospitals & Clinics
4.2.3.2. Diagnostic Centers
4.2.3.3. Others
4.3. Value Chain Analysis
4.4. SWOT Analysis
4.5. Porter’s Five Forces Analysis


5. Regional Market Analysis
5.1. China
5.1.1. Market Overview
5.1.2. Market Size and Forecast
5.1.3. Key Trends
5.1.4. Competitive Landscape
5.2. India
5.2.1. Market Overview
5.2.2. Market Size and Forecast
5.2.3. Key Trends
5.2.4. Competitive Landscape
5.3. Japan
5.3.1. Market Overview
5.3.2. Market Size and Forecast
5.3.3. Key Trends
5.3.4. Competitive Landscape
5.4. South Korea
5.4.1. Market Overview
5.4.2. Market Size and Forecast
5.4.3. Key Trends
5.4.4. Competitive Landscape
5.5. Australia
5.5.1. Market Overview
5.5.2. Market Size and Forecast
5.5.3. Key Trends
5.5.4. Competitive Landscape
5.6. Rest of Asia Pacific
5.6.1. Market Overview
5.6.2. Market Size and Forecast
5.6.3. Key Trends
5.6.4. Competitive Landscape


6. Competitive Landscape
6.1. Market Share Analysis of Key Players
6.2. Company Profiles of Key Players
6.2.1. Siemens Healthineers
6.2.2. GE Healthcare
6.2.3. Philips Healthcare
6.2.4. Canon Medical Systems Corporation
6.2.5. Toshiba Medical Systems Corporation
6.2.6. Bracco Diagnostics Inc.
6.2.7. Nordion Inc.
6.2.8. Eli Lilly and Company
6.2.9. Theragnostics Ltd.
6.2.10. Advanced Accelerator Applications (AAA)
6.3. Recent Developments and Innovations
6.4. Strategic Initiatives


7. Future Outlook and Market Forecast
7.1. Market Growth Prospects
7.2. Technological Trends and Innovations
7.3. Investment Opportunities
7.4. Strategic Recommendations


8. Key Insights and Reiteration of Main Findings

9. Future Prospects for the Asia Pacific Nuclear Medicine Market



List of Figures

List of Figures:

Figure 1: Asia Pacific Nuclear Medicine Market: Market Segmentation
Figure 2: Asia Pacific Nuclear Medicine Market: Research Methodology
Figure 3: Top Down Approach
Figure 4: Bottom Up Approach
Figure 5: Data Triangulation and Validation
Figure 6: Asia Pacific Nuclear Medicine Market: Drivers, Restraints, Opportunities, and Challenges
Figure 7: Asia Pacific Nuclear Medicine Market: Porter’s Five Forces Model Analysis
Figure 8: Asia Pacific Nuclear Medicine Market: Value Chain Analysis
Figure 9: Asia Pacific Nuclear Medicine Market Share Analysis, By Product (Diagnostics and Therapeutics), 2024-2034
Figure 10: Asia Pacific Nuclear Medicine Market Share Analysis, By Diagnostic Product (SPECT, PET), 2024-2034
Figure 11: Asia Pacific Nuclear Medicine Market Share Analysis, By Therapeutic Product (Alpha Emitters, Beta Emitters), 2024-2034
Figure 12: Asia Pacific Nuclear Medicine Market Share Analysis, By Application (Neurology, Cardiology, Oncology, Others), 2024-2034
Figure 13: Asia Pacific Nuclear Medicine Market Share Analysis, By End User (Hospitals & Clinics, Diagnostic Centers, Others), 2024-2034
Figure 14: China Nuclear Medicine Market Share Analysis, By Product (Diagnostics and Therapeutics), 2024-2034
Figure 15: China Nuclear Medicine Market Share Analysis, By Diagnostic Product (SPECT, PET), 2024-2034
Figure 16: China Nuclear Medicine Market Share Analysis, By Therapeutic Product (Alpha Emitters, Beta Emitters), 2024-2034
Figure 17: China Nuclear Medicine Market Share Analysis, By Application (Neurology, Cardiology, Oncology, Others), 2024-2034
Figure 18: China Nuclear Medicine Market Share Analysis, By End User (Hospitals & Clinics, Diagnostic Centers, Others), 2024-2034
Figure 19: India Nuclear Medicine Market Share Analysis, By Product (Diagnostics and Therapeutics), 2024-2034
Figure 20: India Nuclear Medicine Market Share Analysis, By Diagnostic Product (SPECT, PET), 2024-2034
Figure 21: India Nuclear Medicine Market Share Analysis, By Therapeutic Product (Alpha Emitters, Beta Emitters), 2024-2034
Figure 22: India Nuclear Medicine Market Share Analysis, By Application (Neurology, Cardiology, Oncology, Others), 2024-2034
Figure 23: India Nuclear Medicine Market Share Analysis, By End User (Hospitals & Clinics, Diagnostic Centers, Others), 2024-2034
Figure 24: Japan Nuclear Medicine Market Share Analysis, By Product (Diagnostics and Therapeutics), 2024-2034
Figure 25: Japan Nuclear Medicine Market Share Analysis, By Diagnostic Product (SPECT, PET), 2024-2034
Figure 26: Japan Nuclear Medicine Market Share Analysis, By Therapeutic Product (Alpha Emitters, Beta Emitters), 2024-2034
Figure 27: Japan Nuclear Medicine Market Share Analysis, By Application (Neurology, Cardiology, Oncology, Others), 2024-2034
Figure 28: Japan Nuclear Medicine Market Share Analysis, By End User (Hospitals & Clinics, Diagnostic Centers, Others), 2024-2034
Figure 29: South Korea Nuclear Medicine Market Share Analysis, By Product (Diagnostics and Therapeutics), 2024-2034
Figure 30: South Korea Nuclear Medicine Market Share Analysis, By Diagnostic Product (SPECT, PET), 2024-2034
Figure 31: South Korea Nuclear Medicine Market Share Analysis, By Therapeutic Product (Alpha Emitters, Beta Emitters), 2024-2034
Figure 32: South Korea Nuclear Medicine Market Share Analysis, By Application (Neurology, Cardiology, Oncology, Others), 2024-2034
Figure 33: South Korea Nuclear Medicine Market Share Analysis, By End User (Hospitals & Clinics, Diagnostic Centers, Others), 2024-2034
Figure 34: Australia Nuclear Medicine Market Share Analysis, By Product (Diagnostics and Therapeutics), 2024-2034
Figure 35: Australia Nuclear Medicine Market Share Analysis, By Diagnostic Product (SPECT, PET), 2024-2034
Figure 36: Australia Nuclear Medicine Market Share Analysis, By Therapeutic Product (Alpha Emitters, Beta Emitters), 2024-2034
Figure 37: Australia Nuclear Medicine Market Share Analysis, By Application (Neurology, Cardiology, Oncology, Others), 2024-2034
Figure 38: Australia Nuclear Medicine Market Share Analysis, By End User (Hospitals & Clinics, Diagnostic Centers, Others), 2024-2034
Figure 39: Rest of Asia Pacific Nuclear Medicine Market Share Analysis, By Product (Diagnostics and Therapeutics), 2024-2034
Figure 40: Rest of Asia Pacific Nuclear Medicine Market Share Analysis, By Diagnostic Product (SPECT, PET), 2024-2034
Figure 41: Rest of Asia Pacific Nuclear Medicine Market Share Analysis, By Therapeutic Product (Alpha Emitters, Beta Emitters), 2024-2034
Figure 42: Rest of Asia Pacific Nuclear Medicine Market Share Analysis, By Application (Neurology, Cardiology, Oncology, Others), 2024-2034
Figure 43: Rest of Asia Pacific Nuclear Medicine Market Share Analysis, By End User (Hospitals & Clinics, Diagnostic Centers, Others), 2024-2034
Figure 44: Asia Pacific Nuclear Medicine Market: Competitive Benchmarking
Figure 45: Asia Pacific Nuclear Medicine Market: Vendor Share Analysis, 2024
Figure 46: Asia Pacific Nuclear Medicine Market: Regulatory Landscape
Figure 47: Asia Pacific Nuclear Medicine Market: Technological Innovations
Figure 48: Asia Pacific Nuclear Medicine Market: Future Outlook
Figure 49: Asia Pacific Nuclear Medicine Market: Forecast Methodology

List of Tables

List of Tables:

Table 1: Asia Pacific Nuclear Medicine Market, By Product Type, 2024-2034 (USD Million)
Table 2: Asia Pacific Nuclear Medicine Market, By Diagnostics (SPECT and PET), 2024-2034 (USD Million)
Table 3: Asia Pacific Nuclear Medicine Market, By Therapeutics (Alpha Emitters and Beta Emitters), 2024-2034 (USD Million)
Table 4: Asia Pacific Nuclear Medicine Market, By Application, 2024-2034 (USD Million)
Table 5: Asia Pacific Nuclear Medicine Market, By End User, 2024-2034 (USD Million)
Table 6: Asia Pacific Nuclear Medicine Market, By Country, 2024-2034 (USD Million)
Table 7: China Nuclear Medicine Market, By Product Type, 2024-2034 (USD Million)
Table 8: China Nuclear Medicine Market, By Diagnostics (SPECT and PET), 2024-2034 (USD Million)
Table 9: China Nuclear Medicine Market, By Therapeutics (Alpha Emitters and Beta Emitters), 2024-2034 (USD Million)
Table 10: China Nuclear Medicine Market, By Application, 2024-2034 (USD Million)
Table 11: China Nuclear Medicine Market, By End User, 2024-2034 (USD Million)
Table 12: India Nuclear Medicine Market, By Product Type, 2024-2034 (USD Million)
Table 13: India Nuclear Medicine Market, By Diagnostics (SPECT and PET), 2024-2034 (USD Million)
Table 14: India Nuclear Medicine Market, By Therapeutics (Alpha Emitters and Beta Emitters), 2024-2034 (USD Million)
Table 15: India Nuclear Medicine Market, By Application, 2024-2034 (USD Million)
Table 16: India Nuclear Medicine Market, By End User, 2024-2034 (USD Million)
Table 17: Japan Nuclear Medicine Market, By Product Type, 2024-2034 (USD Million)
Table 18: Japan Nuclear Medicine Market, By Diagnostics (SPECT and PET), 2024-2034 (USD Million)
Table 19: Japan Nuclear Medicine Market, By Therapeutics (Alpha Emitters and Beta Emitters), 2024-2034 (USD Million)
Table 20: Japan Nuclear Medicine Market, By Application, 2024-2034 (USD Million)
Table 21: Japan Nuclear Medicine Market, By End User, 2024-2034 (USD Million)
Table 22: South Korea Nuclear Medicine Market, By Product Type, 2024-2034 (USD Million)
Table 23: South Korea Nuclear Medicine Market, By Diagnostics (SPECT and PET), 2024-2034 (USD Million)
Table 24: South Korea Nuclear Medicine Market, By Therapeutics (Alpha Emitters and Beta Emitters), 2024-2034 (USD Million)
Table 25: South Korea Nuclear Medicine Market, By Application, 2024-2034 (USD Million)
Table 26: South Korea Nuclear Medicine Market, By End User, 2024-2034 (USD Million)
Table 27: Australia Nuclear Medicine Market, By Product Type, 2024-2034 (USD Million)
Table 28: Australia Nuclear Medicine Market, By Diagnostics (SPECT and PET), 2024-2034 (USD Million)
Table 29: Australia Nuclear Medicine Market, By Therapeutics (Alpha Emitters and Beta Emitters), 2024-2034 (USD Million)
Table 30: Australia Nuclear Medicine Market, By Application, 2024-2034 (USD Million)
Table 31: Australia Nuclear Medicine Market, By End User, 2024-2034 (USD Million)
Table 32: Rest of Asia Pacific Nuclear Medicine Market, By Product Type, 2024-2034 (USD Million)
Table 33: Rest of Asia Pacific Nuclear Medicine Market, By Diagnostics (SPECT and PET), 2024-2034 (USD Million)
Table 34: Rest of Asia Pacific Nuclear Medicine Market, By Therapeutics (Alpha Emitters and Beta Emitters), 2024-2034 (USD Million)
Table 35: Rest of Asia Pacific Nuclear Medicine Market, By Application, 2024-2034 (USD Million)
Table 36: Rest of Asia Pacific Nuclear Medicine Market, By End User, 2024-2034 (USD Million)
Table 37: Asia Pacific Nuclear Medicine Market Revenue by Product Type, 2024-2034 (USD Million)
Table 38: Asia Pacific Nuclear Medicine Market Volume by Product Type, 2024-2034 (Units)
Table 39: Asia Pacific Nuclear Medicine Market Revenue by Application, 2024-2034 (USD Million)
Table 40: Asia Pacific Nuclear Medicine Market Volume by Application, 2024-2034 (Units)
Table 41: Asia Pacific Nuclear Medicine Market Revenue by End User, 2024-2034 (USD Million)
Table 42: Asia Pacific Nuclear Medicine Market Volume by End User, 2024-2034 (Units)
Table 43: China Nuclear Medicine Market Revenue, 2024-2034 (USD Million)
Table 44: China Nuclear Medicine Market Volume, 2024-2034 (Units)
Table 45: India Nuclear Medicine Market Revenue, 2024-2034 (USD Million)
Table 46: India Nuclear Medicine Market Volume, 2024-2034 (Units)
Table 47: Japan Nuclear Medicine Market Revenue, 2024-2034 (USD Million)
Table 48: Japan Nuclear Medicine Market Volume, 2024-2034 (Units)
Table 49: South Korea Nuclear Medicine Market Revenue, 2024-2034 (USD Million)
Table 50: South Korea Nuclear Medicine Market Volume, 2024-2034 (Units)
Table 51: Australia Nuclear Medicine Market Revenue, 2024-2034 (USD Million)
Table 52: Australia Nuclear Medicine Market Volume, 2024-2034 (Units)
Table 53: Rest of Asia Pacific Nuclear Medicine Market Revenue, 2024-2034 (USD Million)
Table 54: Rest of Asia Pacific Nuclear Medicine Market Volume, 2024-2034 (Units)
Table 55: GE Healthcare: Company Snapshot
Table 56: GE Healthcare: Operating Segments
Table 57: GE Healthcare: Product Portfolio
Table 58: Siemens Healthineers: Company Snapshot
Table 59: Siemens Healthineers: Operating Segments
Table 60: Siemens Healthineers: Product Portfolio
Table 61: Philips Healthcare: Company Snapshot
Table 62: Philips Healthcare: Operating Segments
Table 63: Philips Healthcare: Product Portfolio